Vincristine
Showing 51 - 75 of 1,399
DLBCL Germinal Center B-Cell Type Trial in China (Selinexor, Rituximab, Cyclophosphamide)
Recruiting
- DLBCL Germinal Center B-Cell Type
- Selinexor
- +5 more
-
Guangzhou, Guangdong, China
- +5 more
Aug 16, 2022
Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)
Not yet recruiting
- Leukemia
- Cyclophosphamide
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Dec 23, 2022
Sarcoma, Kaposi, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Bleomycin sulfate
- +4 more
-
Los Angeles, California
- +4 more
Oct 26, 2021
EBV-Positive DLBCL, Nos Trial in Guangzhou, Shanghai (Selinexor, R-CHOP Protocol)
Recruiting
- EBV-Positive Diffuse Large B-Cell Lymphoma, Nos
- Selinexor
- R-CHOP Protocol
-
Guangzhou, Guangdong, China
- +1 more
Nov 10, 2022
Lymphoblastic Lymphoma Trial in Chengdu, Shanghai (Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide,
Active, not recruiting
- Lymphoblastic Lymphoma
- Prednisone,Vincristine, Pegylated-asparaginase, Cytarabine, Cyclophosphamide, Daunorubicin, 6-mercaptopurine
- +6 more
-
Chengdu, China
- +1 more
Mar 17, 2022
Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia
Completed
- Acute Lymphoblastic Leukemia
- Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
- Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 26, 2022
Lymphoma Trial in Scottsdale, Jacksonville, Rochester (biological, drug, genetic, other)
Active, not recruiting
- Lymphoma
- pegfilgrastim
- +8 more
-
Scottsdale, Arizona
- +2 more
Jan 7, 2022
T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)
Not yet recruiting
- T Cell Lymphoma
- Mogamulizumab
- DA-EPOCH Protocol
-
New Haven, ConnecticutYale Smilow Cancer Hospital
Aug 14, 2023
Lymphoma, AIDS-related, Lymphoma, Large B-Cell, Diffuse Trial run by the NCI (Rituximab, Filgrastim, EPOCH)
Active, not recruiting
- Lymphoma, AIDS-related
- Lymphoma, Large B-Cell, Diffuse
- Rituximab
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2022
Hodgkin Lymphoma, DLBCL Trial run by the NCI (campath, Rituximab, EPOCH)
Completed
- Hodgkin Lymphoma
- Diffuse Large B-Cell Lymphoma
- Campath
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 11, 2022
Lymphoblastic Lymphoma Trial in San Diego, Memphis (Prednisone, Vincristine, Daunorubicin)
Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Epirubicin)
Active, not recruiting
- Diffuse Large B-cell Lymphoma
- Rituximab
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Ruijin Hospital
Dec 1, 2022
Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Doxorubicin, Vincristine)
Active, not recruiting
- Hodgkin Lymphoma
- Brentuximab Vedotin
- +3 more
-
Valhalla, New YorkNew York Medical College
Sep 27, 2022
Burkitt Lymphoma, High-grade B-cell Lymphoma, T-cell/Histocyte-rich Large B-cell Lymphoma Trial run by the NCI (Rituximab,
Suspended
- Burkitt Lymphoma
- +4 more
- Rituximab
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Hepatoblastoma Trial in Shanghai (Sodium Thiosulfate Injection, Primary surgery resection, mono CDDP-Group A2)
Recruiting
- Hepatoblastoma
- Sodium Thiosulfate Injection
- +10 more
-
Shanghai, Shanghai, ChinaShanghai Children's Medical Center
Jul 23, 2022
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Trial in Tianjin (Olverembatinib, Venetoclax, prednisone)
Recruiting
- Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Olverembatinib
- +3 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Oct 21, 2022
Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)
Recruiting
- Diffuse Large Cell Lymphoma
- +4 more
- Vincristine
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Nanjing, Nanjin (Zanubrutinib, Lenalidomide, Rituximab)
Recruiting
- Non Hodgkin Lymphoma
- Diffuse Large B Cell Lymphoma
- Zanubrutinib
- +6 more
-
Nanjing, Jiangsu, China
- +1 more
Mar 9, 2022
Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)
Recruiting
- Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
- Vincristine
- +9 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Dec 13, 2022
Sarcoma, Kaposi, HIV Trial in Los Angeles (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Bleomycin sulfate
- +3 more
-
Los Angeles, CaliforniaUCLA CARE Center CRS
Oct 28, 2021
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine
Active, not recruiting
- Lymphoma, Non-Hodgkin
- +5 more
- Rituximab
- +2 more
-
Providence, Rhode IslandRhode Island Hospital and The Miriam Hospital
Jul 19, 2021
Follicular Lymphoma (FL) Trial (biological, drug, other)
Not yet recruiting
- Follicular Lymphoma (FL)
- Tisagenlecleucel
- +4 more
- (no location specified)
May 24, 2023
Follicular Lymphoma (FL) Trial in Noblesville (Odronextamab, Rituximab, Cyclophosphamide)
Recruiting
- Follicular Lymphoma (FL)
- Odronextamab
- +5 more
-
Noblesville, IndianaInvestigative Clinical Research of Indiana
Oct 18, 2023